|
1
|
Xu J, Xia W, Sheng G, Jiao G, Liu Z, Wang Y, Zhang X. Progress of disinfection catalysts in advanced oxidation processes, mechanisms and synergistic antibiotic degradation. THE SCIENCE OF THE TOTAL ENVIRONMENT 2024; 913:169580. [PMID: 38154648 DOI: 10.1016/j.scitotenv.2023.169580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Revised: 12/18/2023] [Accepted: 12/19/2023] [Indexed: 12/30/2023]
Abstract
Human diseases caused by pathogenic microorganisms make people pay more attention to disinfection. Meanwhile, antibiotics can cause microbial resistance and increase the difficulty of disease treatment, resulting in risk of triggering a vicious circle. Advanced oxidation process (AOPs) has been widely studied in the field of synergistic treatment of the two contaminates. This paper reviews the application of catalytic materials and their modification strategies in the context of AOPs for disinfection and antibiotic degradation. It also delves into the mechanisms of disinfection such as the pathways for microbial inactivation and the related influencing factors, which are essential for understanding the pivotal role of catalytic materials in disinfection principles by AOPs. More importantly, the exploratory research on the combined use of AOPs for disinfection and antibiotic degradation is discussed, and the potential and prospects in this field is highlighted. Finally, the limitations and challenges associated with the application of AOPs in disinfection and antibiotic degradation are summarized. It aims to provide a starting point for future research efforts to facilitate the widespread use of advanced oxidation processes in the field of public health.
Collapse
Affiliation(s)
- Jin Xu
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Wannan Xia
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Guo Sheng
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Guanhao Jiao
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Zhenhao Liu
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Yin Wang
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.
| | - Xiaodong Zhang
- School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China
| |
Collapse
|
|
2
|
Scarinci S, Padovan M, Cosci B, Petillo A, Gattini V, Cosentino F, Mignani A, Foddis R, Guglielmi G. Evaluation of Smallpox Vaccination Coverage and Attitude towards Monkeypox Vaccination among Healthcare Workers in an Italian University Hospital. Vaccines (Basel) 2023; 11:1741. [PMID: 38140146 PMCID: PMC10747083 DOI: 10.3390/vaccines11121741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 09/28/2023] [Accepted: 10/09/2023] [Indexed: 12/24/2023] Open
Abstract
(1) Background: In 2022, monkeypox (Mpox) was declared a public health emergency. The European Medicines Agency has authorized the use of Imvanex/Jynneos, a smallpox vaccine, for coverage against pox. Healthcare workers (HCWs) are all considered by the European Centre for Disease Prevention and Control to be at risk, but in Italy, vaccination was offered only to laboratory personnel. The present study aims to investigate smallpox vaccination coverage (VC) that provides protection against Mpox among HCWs in an Italian university hospital and to assess HCWs' attitudes towards the possibility of getting vaccinated against Mpox. (2) Methods: We conducted a cross-sectional survey. 336 HCWs from selected wards were asked to fill out a self-declaration to collect their sex, profession, ward, vaccination status, and attitude toward Mpox vaccination. (3) Results: 60.71% of HCWs involved provided the requested data; 38.7% of them were previously vaccinated against smallpox, which corresponds to 23.5% of the total HCWs in the wards considered. Considering those born before 1979 as vaccinated, VC increases from 23.5% to 41.7%; the percentage of HCWs who adhered to vaccination is 23%; laboratory technicians showed a lower willingness to be vaccinated. The ward with the highest willingness to vaccinate is proctological surgery. (4) Conclusions: Based on our experience, a variability in smallpox VC and in willingness to vaccination has emerged both among different job titles and age categories and across the wards analyzed. Additionally, our survey reveals that vaccination attitudes are higher among HCWs from wards that currently do not have free access to such vaccinations.
Collapse
Affiliation(s)
- Sergio Scarinci
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy;
| | - Martina Padovan
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy;
| | - Bianca Cosci
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy;
| | - Armando Petillo
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy;
| | - Vittorio Gattini
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
| | - Francesca Cosentino
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
| | - Aldo Mignani
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
| | - Rudy Foddis
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy;
| | - Giovanni Guglielmi
- Occupational Preventive Medicine Ward, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; (S.S.); (M.P.); (B.C.); (A.P.); (V.G.); (F.C.); (A.M.)
| |
Collapse
|
|
3
|
Estévez S, Vara M, Gamo M, Manzano S, Troya J, Botezat E, Jiménez E, Pedrero-Tomé R, Martin MÁ, de la Cueva P, Fernández E, Fernández B, Brown DE, Palma E, Simón A. Epidemiological and Clinical Characteristics of Patients Admitted to a Secondary Hospital with Suspected MPOX Virus Infection: Is HIV Playing a Role? J Clin Med 2023; 12:4124. [PMID: 37373818 DOI: 10.3390/jcm12124124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Revised: 06/09/2023] [Accepted: 06/15/2023] [Indexed: 06/29/2023] Open
Abstract
MPOX (monkeypox) is a zoonotic viral disease, endemic in some Central and West African countries. However, in May 2022, cases began to be reported in non-endemic countries, demonstrating community transmission. Since the beginning of the outbreak, different epidemiological and clinical behaviors have been observed. We conducted an observational study at a secondary hospital in Madrid to characterize suspected and confirmed cases of MPOX epidemiologically and clinically. Besides the general descriptive analysis, we compared data between HIV-positive and HIV-negative subjects; 133 patients were evaluated with suspected MPOX, of which 100 were confirmed. Regarding positive cases, 71.0% were HIV positive, and 99.0% were men with a mean age of 33. In the previous year, 97.6% reported having sex with men, 53.6% used apps for sexual encounters, 22.9% practiced chemsex, and 16.7% went to saunas. Inguinal adenopathies were significantly higher in MPOX cases (54.0% vs. 12.1%, p < 0.001), as the involvement of genital and perianal area (57.0% vs. 27.3% and 17.0% vs. 1.0%, p = 0.006 and p = 0.082 respectively). Pustules were the most common skin lesion (45.0%). In HIV-positive cases, only 6.9% had a detectable viral load, and the mean CD4 count was 607.0/mm3. No significant differences were observed in the disease course, except for a greater tendency towards the appearance of perianal lesions. In conclusion, the MPOX 2022 outbreak in our area has been related to sexual intercourse among MSM, with no severe clinical cases nor apparent differences in HIV and non-HIV patients.
Collapse
Affiliation(s)
- Samuel Estévez
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Marta Vara
- Department of Preventive Medicine and Public Health, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - María Gamo
- Department of Dermatology, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Samuel Manzano
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Jesús Troya
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Ekaterina Botezat
- Department of Preventive Medicine and Public Health, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Eva Jiménez
- Department of Preventive Medicine and Public Health, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Roberto Pedrero-Tomé
- Foundation for Biomedical Research and Innovation (FIIB), Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - María Ángeles Martin
- Department of Dermatology, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Pablo de la Cueva
- Department of Dermatology, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Elisa Fernández
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Beatriz Fernández
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - David Esteban Brown
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Elena Palma
- Department of Internal Medicine, Infanta Leonor University Hospital, 28031 Madrid, Spain
| | - Ana Simón
- Department of Dermatology, Infanta Leonor University Hospital, 28031 Madrid, Spain
| |
Collapse
|